Appropriate antimicrobial therapy in the era of multidrug-resistant human pathogens

Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
J M PogueD Marchaim

Abstract

The past decade has brought a significant rise in antimicrobial resistance, and the ESKAPE pathogens have become a significant threat to public health. Three epidemiological features that negatively impact patients, which are consistently seen with the ESKAPE pathogens, are the following: 1) there has been a rise in incidence of these organisms as causative human pathogens, 2) there has been a significant increase in antimicrobial resistance in these bacterial species, and 3) the infections caused by these resistant strains are associated with worse outcomes when compared with infections caused by their susceptible counterparts. Significant delays in time to appropriate antimicrobial therapy of up to 5 days have been reported in infections due to these organisms and this is the strongest predictor of mortality with ESKAPE pathogens, particular in critically ill patients, where every hour delay has an incremental survival disadvantage for patients. Strategies to decrease these delays are urgently needed. Although routine broad-spectrum empiric coverage for these organisms would ideally limit this delay, agents with activity against these organisms are sometimes less effective, have significant toxicity risk, and their use can re...Continue Reading

References

Oct 1, 1995·The Journal of Infectious Diseases·D K ShayW R Jarvis
Jan 1, 1997·The Journal of Hospital Infection·G G RaoD Kolokithas
May 23, 1998·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·G M LucasR D Moore
Jul 6, 2000·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·B D Cookson
May 29, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·David L Paterson
Jul 23, 2002·Journal of Medical Microbiology·Luis AliagaFernando Cobo
Dec 20, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Sara E CosgroveYehuda Carmeli
Oct 9, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Evelina TacconelliErika M C D'Agata
Feb 12, 2005·Emerging Infectious Diseases·Aharon AbboYehuda Carmeli
Mar 11, 2005·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Sara E CosgroveYehuda Carmeli
Mar 29, 2005·The Lancet Infectious Diseases·Mical Paul, Leonard Leibovici
May 4, 2005·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Keith S KayeYehuda Carmeli
Dec 27, 2005·Antimicrobial Agents and Chemotherapy·Valerie AloushYehuda Carmeli
Jun 17, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Brian A PotoskiDavid L Paterson
Nov 17, 2006·The New England Journal of Medicine·Yardena Siegman-Igra, David A Talan
Dec 30, 2006·Antimicrobial Agents and Chemotherapy·Regina B OsihAnthony D Harris
Jun 22, 2007·Critical Care Medicine·David L Paterson, Jeffrey Lipman
Jul 28, 2007·Pharmacotherapy·Gail E ReidNina M Clark
Oct 6, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·David L Paterson, Yohei Doi
Jun 6, 2008·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·D MarchaimM Weinberger
Oct 25, 2008·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Alicia I HidronUNKNOWN Participating National Healthcare Safety Network Facilities
Oct 29, 2008·Journal of the American College of Surgeons·Stephan HarbarthDidier Pittet
Nov 28, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Helen W BoucherJohn Bartlett
Dec 25, 2008·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Michael RybakDonald P Levine
Apr 28, 2009·Infectious Disease Clinics of North America·Mical Paul, Leonard Leibovici
Sep 3, 2009·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·D MarchaimY Carmeli
Sep 11, 2009·International Journal of Antimicrobial Agents·Ayşe ErbayNeriman Balaban
Dec 3, 2009·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Ebbing LautenbachMyoung Kim
Mar 10, 2010·Antimicrobial Agents and Chemotherapy·Tara ReddyKeith S Kaye
May 14, 2010·The New England Journal of Medicine·Anton Y Peleg, David C Hooper
Aug 25, 2010·Antimicrobial Agents and Chemotherapy·Mical PaulLeonard Leibovici
Oct 16, 2010·The Journal of Antimicrobial Chemotherapy·Mical PaulLeonard Leibovici
Jan 11, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Catherine LiuHenry F Chambers
Jan 14, 2011·Epidemiology and Infection·M TumbarelloM Bassetti
Apr 5, 2011·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Jason M PogueDaryl D DePestel
Jun 15, 2011·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Anthony D HarrisJon P Furuno
Jul 29, 2011·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·A-P MagiorakosD L Monnet
Aug 11, 2011·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Dror MarchaimKeith S Kaye

❮ Previous
Next ❯

Citations

Mar 11, 2015·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·M Paul, G Greub
Mar 11, 2015·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·O OpotaG Greub
Oct 16, 2015·Bioorganic & Medicinal Chemistry Letters·Rajmohan RajamuthiahEleftherios Mylonakis
Sep 12, 2015·ACS Applied Materials & Interfaces·Malte GrünerCristian A Strassert
May 22, 2016·Infectious Disease Clinics of North America·Keith S KayeJian Li
Sep 24, 2016·Infectious Disease Clinics of North America·Amos AdlerDror Marchaim
Oct 8, 2016·Annals of Intensive Care·Gabor ZilahiIgnacio Martin-Loeches
Aug 21, 2016·Letters in Applied Microbiology·J S FranklyneN Chandrasekaran
Jan 3, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Karolina WitekClaus Jacob
Aug 15, 2018·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Tzach AvivDror Marchaim
Oct 12, 2019·The Analyst·Olja Simoska, Keith J Stevenson
Aug 6, 2019·Frontiers in Cellular and Infection Microbiology·Carolina Domínguez-DíazMary Fafutis-Morris
Aug 17, 2019·Antimicrobial Resistance and Infection Control·Xuemei ZhenHengjin Dong
Sep 24, 2020·Internal and Emergency Medicine·Yarden ZoharRonit Koren
Jul 18, 2017·Frontiers in Cellular and Infection Microbiology·Hamed Haddad KashaniRezvan Moniri
Apr 3, 2018·The Journal of Antimicrobial Chemotherapy·Giulia De AngelisMaurizio Sanguinetti
Oct 13, 2018·Marine Drugs·Danielle H DemersBill J Baker
Jun 8, 2018·Frontiers in Microbiology·Deepti P KarumathilKumar Venkitanarayanan
Jul 29, 2020·The Journal of Microbiology·Shivakumar S Jalde, Hyun Kyung Choi
Mar 19, 2020·Frontiers in Medicine·Rhea LewisColin Hill
Jul 9, 2020·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J W Timotëus DeelenUNKNOWN ESBL-PREDICT Study Team
Nov 7, 2020·Journal of Medical Microbiology·Miriam CordovanaSimone Ambretti
Sep 4, 2017·Trends in Biotechnology·Edgar D Goluch
Mar 20, 2021·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Shani Zilberman-ItskovichDror Marchaim

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Carbapenems

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Carbapenems (ASM)

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Acinetobacter Infections

Acinetobacter infections have become common in hospitalized patients, especially in the intensive care unit setting and are difficult to treat due to their propensity to develop antimicrobial drug resistance. Discover the latest research on Acinetobacter Infections here.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.